Orthofix Medical Inc. Proceeds from (Repayments of) Restricted Cash, Financing Activities
Orthofix Medical Inc. (OFIX) reported Proceeds from (Repayments of) Restricted Cash, Financing Activities of $34.42 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-02-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities · last filed 2018-02-26
- Orthofix Medical Inc. proceeds from (repayments of) restricted cash, financing activities for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- Orthofix Medical Inc. proceeds from (repayments of) restricted cash, financing activities for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- Orthofix Medical Inc. proceeds from (repayments of) restricted cash, financing activities for the quarter ending 2015-06-30 was $27.25M.
- Orthofix Medical Inc. proceeds from (repayments of) restricted cash, financing activities for the quarter ending 2015-03-31 was $7.17M, a 59.28% increase year-over-year.
- Orthofix Medical Inc. proceeds from (repayments of) restricted cash, financing activities for fiscal 2015 was $34.42M.
- Orthofix Medical Inc. proceeds from (repayments of) restricted cash, financing activities for fiscal 2014 was -$10.66M.
- Orthofix Medical Inc. proceeds from (repayments of) restricted cash, financing activities for fiscal 2013 was -$2.38M, a 109.21% decline from fiscal 2012.
- Orthofix Medical Inc. proceeds from (repayments of) restricted cash, financing activities for fiscal 2012 was $25.80M.
| Period end | Proceeds from (Repayments of) Restricted Cash, Financing Activities 3 month | Proceeds from (Repayments of) Restricted Cash, Financing Activities 6 month | Proceeds from (Repayments of) Restricted Cash, Financing Activities 9 month | Proceeds from (Repayments of) Restricted Cash, Financing Activities 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $0.00 derived: sum of 2 quarters · filed 2018-02-26 | $27.25M derived: sum of 3 quarters · filed 2018-02-26 | $34.42M 10-K · filed 2018-02-26 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $27.25M derived: sum of 2 quarters · filed 2016-10-31 | $34.42M 10-Q · filed 2016-10-31 | $34.78M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $27.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $34.42M 10-Q · filed 2016-08-01 | $34.78M derived: sum of 3 quarters · filed 2017-02-27 | $45.17M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $7.17M 10-Q · filed 2016-04-28 | $7.53M derived: sum of 2 quarters · filed 2017-02-27 | $17.91M derived: sum of 3 quarters · filed 2017-02-27 | -$7.99M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $361.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $10.74M derived: sum of 2 quarters · filed 2017-02-27 | -$15.16M derived: sum of 3 quarters · filed 2017-02-27 | -$10.66M 10-K · filed 2017-02-27 |
| 2014-09-30 | $10.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | -$15.53M derived: sum of 2 quarters · filed 2015-11-03 | -$11.02M 10-Q · filed 2015-11-03 | -$12.03M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$25.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$21.41M 10-Q · filed 2015-08-04 | -$22.41M derived: sum of 3 quarters · filed 2016-02-29 | -$24.50M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $4.50M 10-Q · filed 2015-05-18 | $3.50M derived: sum of 2 quarters · filed 2016-02-29 | $1.41M derived: sum of 3 quarters · filed 2016-02-29 | $10.27M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$3.10M derived: sum of 2 quarters · filed 2016-02-29 | $5.77M derived: sum of 3 quarters · filed 2016-02-29 | -$2.38M 10-K · filed 2016-02-29 |
| 2013-09-30 | -$2.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-31 | $6.77M derived: sum of 2 quarters · filed 2015-03-31 | -$1.37M 10-Q · filed 2015-03-31 | $44.65M derived: sum of 4 quarters · filed 2015-04-29 |
| 2013-06-30 | $8.86M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-03-31 | $721.00K 10-Q · filed 2015-03-31 | $46.74M derived: sum of 3 quarters · filed 2015-04-29 | $52.35M derived: sum of 4 quarters · filed 2015-04-29 |
| 2013-03-31 | -$8.14M 10-Q/A · filed 2015-03-31 | $37.88M derived: sum of 2 quarters · filed 2015-04-29 | $43.49M derived: sum of 3 quarters · filed 2015-04-29 | $49.93M derived: sum of 4 quarters · filed 2015-04-29 |
| 2012-12-31 | $46.02M derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-29 | $51.63M derived: sum of 2 quarters · filed 2015-04-29 | $58.07M derived: sum of 3 quarters · filed 2015-04-29 | $25.80M 10-K · filed 2015-04-29 |
| 2012-09-30 | $5.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-25 | $12.05M derived: sum of 2 quarters · filed 2014-03-25 | -$20.22M 10-Q · filed 2014-03-25 | -$30.11M derived: sum of 4 quarters · filed 2015-03-31 |
| 2012-06-30 | $6.44M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2014-03-24 | -$25.83M 10-Q · filed 2014-03-24 | -$35.72M derived: sum of 3 quarters · filed 2015-03-31 | -$47.72M derived: sum of 4 quarters · filed 2015-03-31 |
| 2012-03-31 | -$32.27M 10-Q/A · filed 2014-03-24 | -$42.16M derived: sum of 2 quarters · filed 2015-03-31 | -$54.16M derived: sum of 3 quarters · filed 2015-03-31 | -$54.01M derived: sum of 4 quarters · filed 2015-03-31 |
| 2011-12-31 | -$9.89M derived: 10-K/A 12 month − 10-Q 9 month · filed 2015-03-31 | -$21.89M derived: sum of 2 quarters · filed 2015-03-31 | -$21.74M derived: sum of 3 quarters · filed 2015-03-31 | -$24.18M 10-K/A · filed 2015-03-31 |
| 2011-09-30 | -$12.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | -$11.85M derived: sum of 2 quarters · filed 2012-11-02 | -$14.29M 10-Q · filed 2012-11-02 | -$15.24M derived: sum of 4 quarters · filed 2014-03-24 |
| 2011-06-30 | $157.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30 | -$2.29M 10-Q · filed 2012-07-30 | -$3.24M derived: sum of 3 quarters · filed 2014-03-24 | -$5.82M derived: sum of 4 quarters · filed 2014-03-24 |
| 2011-03-31 | -$2.44M 10-Q · filed 2012-05-04 | -$3.39M derived: sum of 2 quarters · filed 2014-03-24 | -$5.97M derived: sum of 3 quarters · filed 2014-03-24 | |
| 2010-12-31 | -$951.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-03-24 | -$3.53M derived: sum of 2 quarters · filed 2014-03-24 | -$11.29M 10-K/A · filed 2014-03-24 | |
| 2010-09-30 | -$2.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | -$10.34M 10-Q · filed 2011-10-31 | ||
| 2010-06-30 | -$7.76M 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | -$612.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |